oHCM Webinar Series: Comprehensive Management of oHCM - A Team-Based Perspective

This dynamic educational activity equips healthcare professionals with practical, up-to-date knowledge to improve outcomes for patients with obstructive hypertrophic cardiomyopathy (oHCM). Participants will evaluate pharmacologic treatments—including cardiac myosin inhibitors—by examining mechanisms of action, side effects, and patient-specific considerations. The program also highlights the critical role of nurses and advanced practice providers in patient assessment, lifestyle education, interdisciplinary care, and medication management. Learners will explore the indications and outcomes of surgical interventions like septal myectomy and gain strategies for recognizing and responding to arrhythmias in oHCM. Guided by experts from a recognized HCM Center of Excellence—with over a decade of experience treating patients and leading clinical trials—participants will gain firsthand insights into best practices in specialized care. Join us to enhance diagnostic accuracy, apply timely interventions, and stay at the forefront of oHCM care.

Free to all learners 

Once you’ve completed registration, return to the homepage and click on the Begin tab to complete the pre-test before the start of the course.

1. Evaluate the effectiveness of different pharmacological treatments for hypertrophic cardiomyopathy, discussing the mechanisms of action, potential side effects, and patient-specific factors that influence therapy selection, including cardiac myosin inhibitors
2. Illustrate the role of nurses and advanced practice providers in the care of patients with hypertrophic cardiomyopathy, including patient assessment, education on lifestyle modifications, coordination of interdisciplinary care, and specialty medication management.
3. Describe the indications, procedures, and outcomes associated with surgical interventions for hypertrophic cardiomyopathy, including septal myectomy
4. Interpret the significance of arrhythmias in patients with hypertrophic cardiomyopathy, and propose appropriate clinical responses or interventions based on the identified arrhythmias

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 
 
Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Live Activity for a maximum of 1.50 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this live activity for a maximum of 1.5 ANCC contact hours.  

American Academy of Physician Associates (AAPA) - Live  Stanford Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This live activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.  

Cancellation Policy
Live Activities: Cancellations received in writing no less than 20 days before the course will be refunded. No refunds will be made on cancellations received after that date. Any cancellations refunded will less a 20% administrative fee. Please send cancellation requests to [email protected].

Stanford University School of Medicine reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs, such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require visual, auditory, cognitive, or mobility accommodations, please contact the CME office.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

For activity related questions, please contact    
Amanda Harrison     
Education Events Specialist     
[email protected] 

For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

Disclosure of faculty and their commercial relationships will be made prior to the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Victoria Parikh, MD
Assistant Professor of Medicine (Cardiovascular Medicine)
Stanford University School of Medicine

Course Director

Paid consultant-Lexeo Therapeutics|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Lexeo Therapeutics

William Hiesinger, MD
Associate Professor of Cardiothoracic Surgery
Stanford University School of Medicine

Faculty

Nothing to disclose

Marco Valentin Perez, MD
Associate Professor of Medicine (Cardiovascular Medicine)
Stanford University School of Medicine

Faculty

Consulting Fee-Apple Inc.|Grant or research support-NIH|Ownership-QALY|Consulting Fee-Biotronik, Inc. (Relationship has ended)|Consulting Fee-Boston Scientific Corporation|Advisor-Thryv Inc.|Advisor-Bristol-Myers Squibb|Advisor-Johnson and Johnson|Grant or research support-Johnson and Johnson

Heidi Joy Salisbury, CNS
Program Operations Coordinator Stanford Center for Inherited Cardiovascular Disease
Stanford Healh Care

Faculty

Matthew Thomas Wheeler, MD
Assistant Professor
SHC

Faculty

Grant or research support-Bristol-Myers Squibb|Grant or research support-Novartis AG (Relationship has ended)|Grant or research support-Pfizer, Inc. (Relationship has ended)|Grant or research support-Salubris|Consulting Fee-Cytokinetics|Grant or research support-Alexion|Grant or research support-Eidos|Stocks or stock options, excluding diversified mutual funds-Personalis

Masataka Kawana, MD
Assistant Professor
Stanford University

Faculty, Planner

Advisor-Cardiac RSK3 Inhibitors, LLC|Advisor-Edwards Lifesciences LLC|Advisor-Holosis Health Inc.

Tia Moscarello, MS
Genetic Counselor, Clinical Assistant Professor
Stanford Health Care

Faculty, Planner and Reviewer

Nothing to disclose

Ruth Adewuya, MD
Managing Director
Stanford University School of Medicine

Planner

Nothing to disclose

Tuesday, September 30, 2025

This CME Activity is supported by an educational grant from Bristol Myers Squibb.